Short answer · Medically reviewed summary · Last updated: 2026-04-07
Gillespie syndrome does not have a unique, dedicated ICD-10 or ICD-9 code; it is typically classified under broader categories for rare congenital malformation syndromes or specific ocular anomalies. Clinicians often use Q13.1 (Absence of iris/Aniridia) or Q87.8 (Other specified congenital malformation syndromes) in ICD-10 to facilitate billing and medical record tracking for patients with Gillespie syndrome. What is Gillespie syndrome and how is it classified? Gillespie syndrome is an extremely rare genetic condition characterized by a triad of partial aniridia (absence of part of the iris), non-progressive ataxia (problems with balance and coordination), and intellectual disability.
Gillespie syndrome does not have a unique, dedicated ICD-10 or ICD-9 code; it is typically classified under broader categories for rare congenital malformation syndromes or specific ocular anomalies. Clinicians often use Q13.1 (Absence of iris/Aniridia) or Q87.8 (Other specified congenital malformation syndromes) in ICD-10 to facilitate billing and medical record tracking for patients with Gillespie syndrome.
Gillespie syndrome is an extremely rare genetic condition characterized by a triad of partial aniridia (absence of part of the iris), non-progressive ataxia (problems with balance and coordination), and intellectual disability. Because Gillespie syndrome is so rare, it lacks an individualized code in the International Classification of Diseases (ICD) systems. Medical professionals must use proxy codes that describe the primary clinical findings, such as the iris hypoplasia or the associated neurological features, to ensure that patients receive appropriate care and documentation.
The diagnosis of Gillespie syndrome is primarily clinical, based on the presence of the classic triad of symptoms. Ophthalmological examination is essential to identify the characteristic "fixed" or scalloped appearance of the iris. Genetic testing is increasingly used to confirm the diagnosis, specifically by identifying pathogenic variants in the PAX6 gene or, more commonly in recent literature, the ITPR1 gene. Because Gillespie syndrome presents differently in every individual, a multidisciplinary approach is required to assess the extent of neurological and ocular involvement.
Gillespie syndrome is typically inherited in an autosomal dominant pattern. This means that a single copy of a mutated gene is sufficient to cause the condition. However, many cases of Gillespie syndrome occur as *de novo* mutations, meaning the genetic change happens spontaneously in the individual without a family history. Genetic counseling is highly recommended for families affected by Gillespie syndrome to understand the recurrence risks and the implications for future pregnancies.
While the clinical presentation varies, patients identified with Gillespie syndrome often exhibit the following core characteristics:
Living with a rare diagnosis can feel isolating, but you are not alone. Currently, 9 people with Gillespie syndrome have joined the DiseaseMaps.org community to share their experiences, navigate diagnostic challenges, and support one another through the complexities of this rare condition. Connecting with others who understand the unique path of Gillespie syndrome can provide invaluable emotional and practical support.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.